Propafenone Hydrochloride Extended-Release Capsules
CGMP Deviations
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Failed moisture limits: Out of specification for moisture content.
Cause type: Failed specification
A physical or chemical test other than potency, dissolution, impurity or stability failed - pH, viscosity, appearance, tablet integrity, fill volume. A product outside its own specification may not perform as designed, even if the active ingredient is present. All failed specification recalls.
Propafenone Hydrochloride tablets, 150 mg, packaged in 10 x 10 unit dose cards (100-count box), Rx only, Manufactured By: Watson Pharmaceuticals 311 Bonnie Circle Corona, CA 92880, NDC 63739-509-10
Compare with the code on your package — it is the most precise check available.
Drug: Propafenone
Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.
CGMP Deviations
CGMP Deviations
CGMP Deviations
CGMP Deviations
Labeling: Label Mixup: PROPAFENONE HCL, Tablet, 150 mg may have potentially been mislabeled as the following drug: FOSINOPRIL SODIUM, Tablet, 10 mg, NDC 00185004109, Pedigree: AD54549_7, EXP: 5/20/2014.
Failed Dissolution Specifications. High dissolution results were obtained during stability testing.
Failed Dissolution Specifications. High dissolution results were obtained during stability testing.
Failed Dissolution Specifications. High dissolution results were obtained during stability testing.
Failed Stability Specifications
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.